- Home
- FBRT vs MDXG Comparison
FBRT vs MDXG Comparison
Compare FBRT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRT
- MDXG
- Stock Information
- Founded
- FBRT 2012
- MDXG 2006
- Country
- FBRT United States
- MDXG United States
- Employees
- FBRT N/A
- MDXG N/A
- Industry
- FBRT Real Estate Investment Trusts
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- FBRT Real Estate
- MDXG Health Care
- Exchange
- FBRT Nasdaq
- MDXG Nasdaq
- Market Cap
- FBRT 933.1M
- MDXG 877.4M
- IPO Year
- FBRT 1985
- MDXG N/A
- Fundamental
- Price
- FBRT $10.97
- MDXG $6.67
- Analyst Decision
- FBRT Strong Buy
- MDXG Strong Buy
- Analyst Count
- FBRT 6
- MDXG 2
- Target Price
- FBRT $15.25
- MDXG $12.50
- AVG Volume (30 Days)
- FBRT 727.5K
- MDXG 771.8K
- Earning Date
- FBRT 07-30-2025
- MDXG 07-30-2025
- Dividend Yield
- FBRT 12.93%
- MDXG N/A
- EPS Growth
- FBRT N/A
- MDXG N/A
- EPS
- FBRT 0.67
- MDXG 0.27
- Revenue
- FBRT $175,693,000.00
- MDXG $352,375,000.00
- Revenue This Year
- FBRT $29.44
- MDXG $9.55
- Revenue Next Year
- FBRT $2.22
- MDXG $11.43
- P/E Ratio
- FBRT $16.39
- MDXG $25.11
- Revenue Growth
- FBRT N/A
- MDXG 5.34
- 52 Week Low
- FBRT $10.50
- MDXG $5.47
- 52 Week High
- FBRT $14.12
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- FBRT 49.97
- MDXG 57.60
- Support Level
- FBRT $10.69
- MDXG $5.86
- Resistance Level
- FBRT $11.06
- MDXG $7.05
- Average True Range (ATR)
- FBRT 0.18
- MDXG 0.24
- MACD
- FBRT 0.03
- MDXG 0.11
- Stochastic Oscillator
- FBRT 70.80
- MDXG 69.20
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.